Prescient Metabiomics has developed LifeKit PREVENT, a non‑invasive stool‑based microbiome diagnostic test for colorectal neoplasia that has received FDA Breakthrough Device designation for detecting both colorectal cancer and precancerous adenomas, with clinical research suggesting >80% accuracy for detecting precancerous colon polyps[8][9].
Therapeutic areas
OncologyGastroenterology
Modalities
Diagnostic testIn-vitro diagnostic
Industry
Molecular Diagnostics
02
Partnerships
CoreBiome (OraSure Technologies subsidiary) – collaboration on metagenomic sequencing and analytics for LifeKit PREVENT colorectal cancer screening test[1].Harvard T.H. Chan School of Public Health Microbiome in Public Health Center – research collaboration on microbial biomarkers for colon cancer screening[2][7].Prescient Medicine/SOLVD Health – joint venture and ongoing integration to develop microbiome-based GI health diagnostics including LifeKit PREVENT[3][8][11].Multiple academic medical centers (e.g., George Mason University, Rush University Medical Center, Virginia Commonwealth University, Case Western Reserve University, University of Calgary, Mayo Clinic, Boston University) for microbiome clinical research in gastrointestinal diseases[4].
Beyond the preview
Go deeper on Prescient Metabiomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile access
Follow clinical development from trial design and recruitment through results.
Trial phase
Status
Readouts
Licensing & deals
Full profile access
Explore licensing agreements, acquisitions, and the assets behind each deal.
Partners
Deal terms
Milestones
Funding history
Full profile access
Trace financing activity and the investors behind a company’s development.
Funding rounds
Investors
Capital raised
Competitive landscape
Full profile access
Compare peer pipelines by target, modality, and therapeutic area.
Peer companies
Targets
Pipeline overlap
Technologies & patents
Full profile access
Explore technology platforms and the patent landscape around relevant assets.
Platforms
Patents
Assignees
Research & analysis
Full profile access
Connect company news and source material to the questions you’re investigating.
Company news
Sources
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prescient Metabiomics.